WebBy Neil H. Riordan, PA, PhD and Thomas Ichim, PhD. MSC is a first-of-its-kind publication spanning more than 50 years of research and clinical trials. The authors have carefully outlined and summarized key publications drawing from more than 800 unique references, reviewing mesenchymal stem cell treatment for 44 different medical conditions. Web1 day ago · RT @rrao111: IMO, this data is from the limited number of patients who were brave enough to seek help & who were subjectively diagnosed. The magnitude of the problem ...
www.businesswire.com
WebOct 19, 2024 · Dr. Thomas Ichim @exosome Peer reviewed paper I was honored to co-author on the use Mesenchymal Stem Cells for treatment of #COVID19 $tsoi is … WebDec 10, 2012 · Dr. Thomas Ichim Retweeted. Ammar Al-Chalabi. @AmmarAlChalabi. ·. 17h. 30 years ago today the first cause of #ALS #MND was found by Prof Robert H Brown Jr and his team. Now we have … myappsanywhere outlook access
Dr. Thomas Ichim Appointed President and Chief …
WebMar 27, 2024 · ELK CITY, Idaho, March 27, 2024--Therapeutic Solutions International (TSOI) Spin Off Company Campbell Neurosciences announced today the appointment of … WebMar 27, 2024 · Dr. Ichim is the inventor of over 300 published or issued patent applications and author of over 120 peer reviewed papers. “Together with Thomas Ichim and Timothy Dixon, we started Campbell Neurosciences to scientifically validate that in some cases suicide needs to be treated like a disease with biological underpinnings,” said Kalina O ... Webwww.businesswire.com myappsflhealth